Back to Journals » Clinical Pharmacology: Advances and Applications » Volume 10

The effect of combined treatment with sodium phenylbutyrate and cisplatin, erlotinib, or gefitinib on resistant NSCLC cells

Total article views   HTML views PDF downloads Totals
8,939 Dovepress* 8,210+ 1,234 9,444
PubMed Central* 729 157 886
Totals 8,939 1,391 10,330
*Since 9 October 2018
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 1 0 1

View citations on PubMed Central and Google Scholar